Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 77

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Identification of small molecules that interfere with c-di-GMP signaling and induce dispersal of Pseudomonas aeruginosa biofilms

Andersen, Jens Bo, Hultqvist, Louise Dahl, Jansen, Charlotte Uldahl, Jakobsen, Tim Holm, Nilsson, Martin, Rybtke, Morten, Uhd, Jesper, Fritz, Blaine Gabriel, Seifert, Roland, Berthelsen, Jens, Nielsen, Thomas Eiland, Qvortrup, Katrine, Givskov, Michael, Tolker-Nielsen, Tim·2021·npj Biofilms and Microbiomes

Abstract

Microbial biofilms are involved in a number of infections that cannot be cured, as microbes in biofilms resist host immune defenses and antibiotic therapies. With no strict biofilm-antibiotic in the current pipelines, there is an unmet need for drug candidates that enable the current antibiotics to eradicate bacteria in biofilms. We used high-throughput screening to identify chemical compounds that reduce the intracellular c-di-GMP content in Pseudomonas aeruginosa. This led to the identification of a small molecule that efficiently depletes P. aeruginosa for c-di-GMP, inhibits biofilm formation, and disperses established biofilm. A combination of our lead compound with standard of care antibiotics showed improved eradication of an implant-associated infection established in mice. Genetic analyses provided evidence that the anti-biofilm compound stimulates the activity of the c-di-GMP phosphodiesterase BifA in P. aeruginosa. Our work constitutes a proof of concept for c-di-GMP phosphodiesterase-activating drugs administered in combination with antibiotics as a viable treatment strategy for otherwise recalcitrant infections.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41522-021-00225-4

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 72

  1. Costerton, J. W., Stewart, P. S. & Greenberg, E. P. Bacterial biofilms: a common cause of persistent infections. Science 284, 1318–1322 (1999). · DOI · Paper page
  2. Ciofu, O. & Tolker-Nielsen, T. Tolerance and resistance of pseudomonas aeruginosa biofilms to antimicrobial agents-how p. aeruginosa can escape antibiotics. Front. Microbiol. 10, 913 (2019). · DOI · Paper page
  3. Tolker-Nielsen, T. Pseudomonas aeruginosa biofilm infections: from molecular biofilm biology to new treatment possibilities. APMIS Suppl., 1-51, (2014). · DOI
  4. Bryers, J. D. Medical biofilms. Biotechnol. Bioeng. 100, 1–18 (2008). · DOI · Paper page
  5. Bjarnsholt, T. The role of bacterial biofilms in chronic infections. APMIS Supp.l, 1-51, (2013). · DOI · Paper page
  6. Rasmussen, T. B. et al. Identity and effects of quorum-sensing inhibitors produced by Penicillium species. Microbiology 151, 1325–1340 (2005). · DOI · Paper page
  7. Jenal, U., Reinders, A. & Lori, C. Cyclic di-GMP: second messenger extraordinaire. Nat. Rev. Microbiol. 15, 271–284 (2017). · DOI · Paper page
  8. Christensen, L. D. et al. Clearance of Pseudomonas aeruginosa foreign-body biofilm infections through reduction of the cyclic Di-GMP level in the bacteria. Infect. Immun. 81, 2705–2713 (2013). · DOI
  9. Gjermansen, M., Ragas, P. & Tolker-Nielsen, T. Proteins with GGDEF and EAL domains regulate Pseudomonas putida biofilm formation and dispersal. FEMS Microbiol. Lett. 265, 215–224 (2006). · DOI
  10. Gjermansen, M., Nilsson, M., Yang, L. & Tolker-Nielsen, T. Characterization of starvation-induced dispersion in Pseudomonas putida biofilms: genetic elements and molecular mechanisms. Mol. Microbiol. 75, 815–826 (2010). · DOI · Paper page
  11. Andersen, J. B. et al. Induction of native c-di-GMP phosphodiesterases leads to dispersal of Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother., https://doi.org/10.1128/AAC.02431-20 (2021). · DOI
  12. Wood, T. K., Hong, S. H. & Ma, Q. Engineering biofilm formation and dispersal. Trends Biotechnol. 29, 87–94 (2011). · DOI
  13. Opoku-Temeng, C., Zhou, J., Zheng, Y., Su, J. & Sintim, H. O. Cyclic dinucleotide (c-di-GMP, c-di-AMP, and cGAMP) signalings have come of age to be inhibited by small molecules. Chem. Commun. (Camb.) 52, 9327–9342 (2016). · DOI
  14. Jakobsen, T. H., Tolker-Nielsen, T. & Givskov, M. Bacterial biofilm control by perturbation of bacterial signaling processes. Int. J. Mol. Sci. 18, https://doi.org/10.3390/ijms18091970 (2017). · DOI
  15. Antoniani, D. et al. The immunosuppressive drug azathioprine inhibits biosynthesis of the bacterial signal molecule cyclic-di-GMP by interfering with intracellular nucleotide pool availability. Appl. Microbiol. Biotechnol. 97, 7325–7336 (2013). · DOI
  16. Hee, C. S. et al. Intercepting second-messenger signaling by rationally designed peptides sequestering c-di-GMP. Proc. Natl Acad. Sci. USA 117, 17211–17220 (2020). · DOI
  17. Qvortrup, K. et al. Small molecule anti-biofilm agents developed on the basis of mechanistic understanding of biofilm formation. Front. Chem. 7, 742 (2019). · DOI
  18. Zhou, J. et al. Potent suppression of c-di-GMP synthesis via I-site allosteric inhibition of diguanylate cyclases with 2’-F-c-di-GMP. Bioorg. Med. Chem. 21, 4396–4404 (2013). · doi:10.1016/j.bmc.2013.04.050
  19. Ching, S. M., Tan, W. J., Chua, K. L. & Lam, Y. Synthesis of cyclic di-nucleotidic acids as potential inhibitors targeting diguanylate cyclase. Bioorg. Med. Chem. 18, 6657–6665 (2010). · doi:10.1016/j.bmc.2010.07.068
  20. Fernicola, S. et al. Synthesis of triazole-linked analogues of c-di-GMP and their interactions with diguanylate cyclase. J. Med. Chem. 58, 8269–8284 (2015). · doi:10.1021/acs.jmedchem.5b01184
  21. Fernicola, S. et al. In silico discovery and in vitro validation of catechol-containing sulfonohydrazide compounds as potent inhibitors of the diguanylate cyclase PleD. J. Bacteriol. 198, 147–156 (2016). · DOI
  22. Sambanthamoorthy, K. et al. Identification of small molecules inhibiting diguanylate cyclases to control bacterial biofilm development. Biofouling 30, 17–28 (2014). · DOI
  23. Lieberman, O. J., Orr, M. W., Wang, Y. & Lee, V. T. High-throughput screening using the differential radial capillary action of ligand assay identifies ebselen as an inhibitor of diguanylate cyclases. ACS Chem. Biol. 9, 183–192 (2014). · DOI
  24. Christen, M. et al. Identification of small-molecule modulators of diguanylate cyclase by FRET-based high-throughput screening. Chembiochem 20, 394–407 (2019). · DOI
  25. Zheng, Y., Tsuji, G., Opoku-Temeng, C. & Sintim, H. O. Inhibition of P. aeruginosa c-di-GMP phosphodiesterase RocR and swarming motility by a benzoisothiazolinone derivative. Chem. Sci. 7, 6238–6244 (2016). · DOI
  26. Sambanthamoorthy, K. et al. Identification of small molecules that antagonize diguanylate cyclase enzymes to inhibit biofilm formation. Antimicrob. Agents Chemother. 56, 5202–5211 (2012). · DOI · Paper page
  27. Groizeleau, J. et al. The anti-cancerous drug doxorubicin decreases the c-di-GMP content in Pseudomonas aeruginosa but promotes biofilm formation. Microbiology 162, 1797–1807 (2016). · DOI
  28. van Tilburg Bernardes, E., Charron-Mazenod, L., Reading, D. J., Reckseidler-Zenteno, S. L. & Lewenza, S. Exopolysaccharide-repressing small molecules with antibiofilm and antivirulence activity against Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 61, https://doi.org/10.1128/AAC.01997-16 (2017). · DOI
  29. Barraud, N. et al. Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa. J. Bacteriol. 188, 7344–7353 (2006). · DOI · Paper page
  30. Barraud, N. et al. Nitric oxide signaling in Pseudomonas aeruginosa biofilms mediates phosphodiesterase activity, decreased cyclic di-GMP levels, and enhanced dispersal. J. Bacteriol. 191, 7333–7342 (2009). · DOI · Paper page
  31. Cai, Y. M. et al. Differential impact on motility and biofilm dispersal of closely related phosphodiesterases in Pseudomonas aeruginosa. Sci. Rep. 10, 6232 (2020). · DOI
  32. Rybtke, M. T. et al. Fluorescence-based reporter for gauging cyclic di-GMP levels in Pseudomonas aeruginosa. Appl. Environ. Microbiol. 78, 5060–5069 (2012). · DOI · Paper page
  33. Sarenko, O. et al. More than enzymes that make or break cyclic di-GMP-local signaling in the interactome of GGDEF/EAL domain proteins of Escherichia coli. MBio 8, https://doi.org/10.1128/mBio.01639-17 (2017). · DOI
  34. Friedman, L. & Kolter, R. Genes involved in matrix formation in Pseudomonas aeruginosa PA14 biofilms. Mol. Microbiol. 51, 675–690 (2003). · DOI · Paper page
  35. Kuchma, S. L. et al. BifA, a cyclic-Di-GMP phosphodiesterase, inversely regulates biofilm formation and swarming motility by Pseudomonas aeruginosa PA14. J. Bacteriol. 189, 8165–8178 (2007). · DOI · Paper page
  36. Held, K., Ramage, E., Jacobs, M., Gallagher, L. & Manoil, C. Sequence-verified two-allele transposon mutant library for Pseudomonas aeruginosa PAO1. J. Bacteriol. 194, 6387–6389 (2012). · doi:10.1128/jb.01479-12
  37. Serra, D. O., Richter, A. M. & Hengge, R. Cellulose as an architectural element in spatially structured Escherichia coli biofilms. J. Bacteriol. 195, 5540–5554 (2013). · DOI · Paper page
  38. Romling, U., Gomelsky, M. & Galperin, M. Y. C-di-GMP: the dawning of a novel bacterial signalling system. Mol. Microbiol. 57, 629–639 (2005). · DOI · Paper page
  39. Hickman, J. W., Tifrea, D. F. & Harwood, C. S. A chemosensory system that regulates biofilm formation through modulation of cyclic diguanylate levels. Proc. Natl. Acad. Sci. USA 102, 14422–14427 (2005). · DOI · Paper page
  40. Starkey, M. et al. Pseudomonas aeruginosa rugose small-colony variants have adaptations that likely promote persistence in the cystic fibrosis lung. J. Bacteriol. 191, 3492–3503 (2009). · DOI · Paper page
  41. Bernard, C. S., Bordi, C., Termine, E., Filloux, A. & de Bentzmann, S. Organization and PprB-dependent control of the Pseudomonas aeruginosa tad Locus, involved in Flp pilus biology. J. Bacteriol. 191, 1961–1973 (2009). · DOI
  42. Vance, R. E., Hong, S., Gronert, K., Serhan, C. N. & Mekalanos, J. J. The opportunistic pathogen Pseudomonas aeruginosa carries a secretable arachidonate 15-lipoxygenase. Proc. Natl Acad. Sci. USA 101, 2135–2139 (2004). · DOI · Paper page
  43. Deschamps, J. D. et al. Biochemical and Cellular Characterization and Inhibitor Discovery of Pseudomonas aeruginosa 15-Lipoxygenase. Biochemistry 55, 3329–3340 (2016). · DOI
  44. Morello, E. et al. Pseudomonas aeruginosa lipoxygenase LoxA contributes to lung infection by altering the host immune lipid signaling. Front. Microbiol. 10, 1826 (2019). · DOI
  45. Kamal, A. et al. Design and synthesis of pyrazole-oxindole conjugates targeting tubulin polymerization as new anticancer agents. Eur. J. Med. Chem. 92, 501–513 (2015). · doi:10.1016/j.ejmech.2013.10.077
  46. Yamamoto, S. et al. Design, synthesis, and biological evaluation of 4-arylmethyl-1-phenylpyrazole and 4-aryloxy-1-phenylpyrazole derivatives as novel androgen receptor antagonists. Bioorg. Med. Chem. 20, 2338–2352 (2012). · DOI
  47. Fouda, A. M. et al. Synthesis, in vitro antimicrobial and cytotoxic activities of some new pyrazolo[1,5-a]pyrimidine derivatives. Molecules 24, https://doi.org/10.3390/molecules24061080 (2019). · doi:10.3390/molecules24061080
  48. Viveka, S. et al. Design and synthesis of some new pyrazolyl-pyrazolines as potential anti-inflammatory, analgesic and antibacterial agents. Eur. J. Med. Chem. 101, 442–451 (2015). · doi:10.1016/j.ejmech.2015.07.002
  49. Mizuhara, T. et al. Structure-activity relationship study of phenylpyrazole derivatives as a novel class of anti-HIV agents. Bioorg. Med. Chem. Lett. 23, 4557–4561 (2013). · DOI
  50. Tantawy, A. S., Nasr, M. N. A., El-Sayed, M. A. A. & Tawfik, S. S. Synthesis and antiviral activity of new 3-methyl-1,5-diphenyl-1H-pyrazole derivatives. Med. Chem. Res. 21, 4139–4149 (2011). · doi:10.1007/s00044-011-9960-2
  51. Yoshida, T. et al. Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-y lcarbonyl]thiazolidine): a highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. Bioorg. Med. Chem. 20, 5705–5719 (2012). · DOI
  52. Bhatt, J. D., Chudasama, C. J. & Patel, K. D. Pyrazole clubbed triazolo[1,5-a]pyrimidine hybrids as an anti-tubercular agents: Synthesis, in vitro screening and molecular docking study. Bioorg. Med. Chem. 23, 7711–7716 (2015). · doi:10.1016/j.bmc.2015.11.018
  53. Mahfuz Alam, M. S. Z., Alam, M. M., Arora, Karun, Ahmad, Aftab & Husain, Asif Synthesis and antimicrobial activities of new pyrazolo- pyridazine derivatives. Int. J. Pharma. Sci. Res. 6, 495–501 (2015).
  54. Krystof, V. et al. 4-arylazo-3,5-diamino-1H-pyrazole CDK inhibitors: SAR study, crystal structure in complex with CDK2, selectivity, and cellular effects. J. Med. Chem. 49, 6500–6509 (2006). · DOI · Paper page
  55. Jorda, R. et al. Novel arylazopyrazole inhibitors of cyclin-dependent kinases. Bioorg. Med. Chem. 23, 1975–1981 (2015). · DOI
  56. Seifert, R. Basic Knowledge of Pharmacology (Springer, 2019). · DOI
  57. Sandner, P., Becker-Pelster, E. M. & Stasch, J. P. Discovery and development of sGC stimulators for the treatment of pulmonary hypertension and rare diseases. Nitric Oxide 77, 88–95 (2018). · DOI
  58. Xiao, S. et al. Soluble guanylate cyclase stimulators and activators: where are we and where to go? Mini Rev. Med. Chem. 19, 1544–1557 (2019). · DOI
  59. Alt, A. Overview of critical parameters for the design and execution of a high-throughput screen for allosteric ligands. Curr. Protoc. Pharm. 74, 9 20 21–29 20 23 (2016). · DOI
  60. Chambers, J. R., Cherny, K. E. & Sauer, K. Susceptibility of Pseudomonas aeruginosa dispersed cells to antimicrobial agents is dependent on the dispersion cue and class of the antimicrobial agent used. Antimicrob. Agents Chemother. 61, https://doi.org/10.1128/AAC.00846-17 (2017). · DOI · Paper page
  61. Cherny, K. E. & Sauer, K. Untethering and degradation of the polysaccharide matrix are essential steps in the dispersion response of Pseudomonas aeruginosa biofilms. J. Bacteriol. 202, https://doi.org/10.1128/JB.00575-19 (2020). · DOI
  62. Rumbaugh, K. P. & Sauer, K. Biofilm dispersion. Nat. Rev. Microbiol. 18, 571–586 (2020). · DOI · Paper page
  63. Lin Chua, S. et al. Reduced intracellular c-di-GMP content increases expression of quorum sensing-regulated genes in Pseudomonas aeruginosa. Front. Cell Infect. Microbiol. 7, 451 (2017). · DOI
  64. Massie, J. P. et al. Quantification of high-specificity cyclic diguanylate signaling. Proc. Natl. Acad. Sci. USA 109, 12746–12751 (2012). · DOI
  65. Pamp, S. J. & Tolker-Nielsen, T. Multiple roles of biosurfactants in structural biofilm development by Pseudomonas aeruginosa. J. Bacteriol. 189, 2531–2539 (2007). · DOI · Paper page
  66. An, S., Wu, J. & Zhang, L. H. Modulation of Pseudomonas aeruginosa biofilm dispersal by a cyclic-Di-GMP phosphodiesterase with a putative hypoxia-sensing domain. Appl. Environ. Microbiol. 76, 8160–8173 (2010). · DOI · Paper page
  67. Hoang, T. T., Kutchma, A. J., Becher, A. & Schweizer, H. P. Integration-proficient plasmids for Pseudomonas aeruginosa: site-specific integration and use for engineering of reporter and expression strains. Plasmid 43, 59–72 (2000). · DOI · Paper page
  68. Kovach, M. E. et al. Four new derivatives of the broad-host-range cloning vector pBBR1MCS, carrying different antibiotic-resistance cassettes. Gene 166, 175–176 (1995). · DOI · Paper page
  69. Kulasekara, H. D. Transposon mutagenesis. Methods Mol. Biol. 1149, 501–519 (2014). · doi:10.1007/978-1-4939-0473-0_39
  70. Crusz, S. A. et al. Bursting the bubble on bacterial biofilms: a flow cell methodology. Biofouling 28, 835–842 (2012). · DOI
  71. Christensen, L. D. et al. Synergistic antibacterial efficacy of early combination treatment with tobramycin and quorum-sensing inhibitors against Pseudomonas aeruginosa in an intraperitoneal foreign-body infection mouse model. J. Antimicrob. Chemother. 67, 1198–1206 (2012). · DOI · Paper page
  72. Christensen, L. D. et al. Impact of Pseudomonas aeruginosa quorum sensing on biofilm persistence in an in vivo intraperitoneal foreign-body infection model. Microbiology 153, 2312–2320 (2007). · DOI

Cited by

See all 77

Metadata

Authors
Andersen, J. B., Hultqvist, L. D., Jansen, C. U., Jakobsen, T. H., Nilsson, M., Rybtke, M., Uhd, J., Fritz, B. G., Seifert, R., Berthelsen, J., Nielsen, T. E., Qvortrup, K., Givskov, M., & Tolker-Nielsen, T.
Venue
npj Biofilms and Microbiomes
Published
2021-07-09
Volume
7
Issue
1
ISSN
2055-5008
Cited by
77
References
1
Language
en
Licence
Funders
Det Frie Forskningsråd

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification of small molecules that interfere with c-di-GMP signaling and induce dispersal of Pseudomonas aeruginosa biofilms. https://app.cochat.ai/papers/10.1038/s41522-021-00225-4
The paper
Andersen, J. B., Hultqvist, L. D., Jansen, C. U., Jakobsen, T. H., Nilsson, M., Rybtke, M., Uhd, J., Fritz, B. G., Seifert, R., Berthelsen, J., Nielsen, T. E., Qvortrup, K., Givskov, M., & Tolker-Nielsen, T. (2021). Identification of small molecules that interfere with c-di-GMP signaling and induce dispersal of Pseudomonas aeruginosa biofilms. npj Biofilms and Microbiomes. https://doi.org/10.1038/s41522-021-00225-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.